• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Melanoma patients can skip brain, extremity scans

Article

Imaging the brain and uninvolved extremities during routine whole-body PET/CT of melanoma wastes scanner time and exposes patients to unnecessary radiation, according to a study presented at the 2006 Academy of Molecular Imaging meeting.

Imaging the brain and uninvolved extremities during routine whole-body PET/CT of melanoma wastes scanner time and exposes patients to unnecessary radiation, according to a study presented at the 2006 Academy of Molecular Imaging meeting.

At the University of California, Los Angeles, melanoma patients used to undergo routine whole-body scanning. A dedicated PET study could take up to 75 minutes; newer PET/CT exams could be acquired in 30 minutes. A retrospective review of 300 cases found that only a negligible number of patients developed metastases in initially uninvolved extremities and/or the brain. Melanoma patients should be scanned the same way as other oncology patients, a protocol that would improve scanner efficiency without compromising diagnostic power or patient safety, said lead investigator Dr. Esther Choi.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.